<DOC>
	<DOCNO>NCT00499759</DOCNO>
	<brief_summary>RATIONALE : An individualized exercise program may effective lessen fatigue depression improve quality life patient undergoing chemotherapy leukemia . PURPOSE : This clinical trial study well individualize exercise program work patient receive chemotherapy newly diagnose acute relapse myeloid leukemia lymphoblastic leukemia .</brief_summary>
	<brief_title>Individualized Exercise Programs Patients Receiving Chemotherapy Newly Diagnosed Acute Relapsed Myeloid Leukemia Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine effect , term fitness blood parameter , fatigue level , quality life , individualized prescriptive exercise intervention patient newly diagnose acute relapse myeloid lymphoblastic leukemia undergo chemotherapy . Secondary - Determine feasibility develop exercise program patient . - Assess change cardiovascular endurance , muscular strength , select blood parameter , response inflammatory protein exercise patient . - Evaluate fatigue , depression , quality life patient . OUTLINE : This pilot study . Patients participate individualize prescriptive exercise intervention 3 4 time per week 6 week ( 4 week hospital , 2 week home ) . Exercise begin concurrently first course ( induction therapy ) chemotherapy . Each exercise session consist 3-5 minute light stretch ( stretch component ) , 5-10 minute cycle recumbent bicycle ( cardiorespiratory component ) , 5-15 minute resistance train include hand dumbbell , exercise tubing , rubber band , fit ball ( resistance training component ) , 5-10 minute abdominal exercise ( core muscle component ) . Quality life , fatigue , depression assess baseline weekly study intervention . Blood sample collect baseline week 3 6 cytokine analysis .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose acute relapse myeloid lymphoblastic leukemia Currently receive reinduction therapy designate chemotherapy treatment Expected hospital stay 34 week long Participation study must approve physician directly responsible patient 's care University North Carolina Hospitals PATIENT CHARACTERISTICS : No condition would compromise patient 's ability participate exercise rehabilitation program , include follow : Immune deficiency Acute chronic bone , joint , muscular abnormality Acute chronic respiratory disease Cardiovascular disease PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>fatigue</keyword>
	<keyword>depression</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>musculoskeletal complication</keyword>
	<keyword>acute undifferentiated leukemia</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
	<keyword>untreated adult acute lymphoblastic leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
</DOC>